Checkpoint Therapeutics, Inc.

Checkpoint Therapeutics, Inc. - PE Ratioverified

CKPT

Price:

$4.26

Market Cap:

$367.72M

Checkpoint Therapeutics, Inc. is a clinical-stage company specializing in immunotherapy and targeted oncology. Its mission involves discovering, advancing, and bringing to market innovative therapeutic solutions for individuals battling solid tumor cancers. The company's pipeline features several key candidates, including Cosibelimab, a leading fully-human IgG1 monoclonal antibody. This therapy is designed to directly bind to programmed death ligand-1 (PD-L1), thereby inhibiting its interaction with programmed death receptor-1 and B7.1 receptors. Another significant antibody in development is CK-302, a human agonistic antibody intended to bind and activate signaling within GITR-expressing ce...[Read more]

Industry

Biotechnology

IPO Date

2016-12-19

Stock Exchange

NASDAQ

Ticker

CKPT

The PE Ratio as of June 2026 (TTM) for Checkpoint Therapeutics, Inc. (CKPT) is -3.33

According to Checkpoint Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.33. This represents a change of 106.60% compared to the average of -1.61 of the last 4 quarters.

Checkpoint Therapeutics, Inc. (CKPT) Historical PE Ratio (quarterly & annually)

How has CKPT PE Ratio performed in the past?

The mean historical PE Ratio of Checkpoint Therapeutics, Inc. over the last ten years is -3.86. The current -3.33 PE Ratio has changed 8.52% with respect to the historical average. Over the past ten years (40 quarters), CKPT's PE Ratio was at its highest in in the March 2025 quarter at -0.05. The PE Ratio was at its lowest in in the June 2015 quarter at -21.79.

Quarterly (TTM)
Annual

Average

-3.86

Median

-3.16

Minimum

-8.79

Maximum

-0.72

Checkpoint Therapeutics, Inc. (CKPT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Checkpoint Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 172.69%

Maximum Annual PE Ratio = -0.72

Minimum Annual Increase = -82.74%

Minimum Annual PE Ratio = -8.79

Quarterly (TTM)
Annual
YearPE RatioChange
2024-2.26172.69%
2023-0.8314.82%
2022-0.72-82.74%
2021-4.18-34.85%
2020-6.41160.89%
2019-2.4671.94%
2018-1.43-63.08%
2017-3.87-49.57%
2016-7.67-12.72%

Checkpoint Therapeutics, Inc. (CKPT) Average PE Ratio

How has CKPT PE Ratio performed in the past?

The current PE Ratio of Checkpoint Therapeutics, Inc. (CKPT) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.27

5-year avg

-2.88

10-year avg

-3.86

Checkpoint Therapeutics, Inc. (CKPT) PE Ratio vs. Peers

How is CKPT’s PE Ratio compared to its peers?

Checkpoint Therapeutics, Inc.’s PE Ratio is greater than Vigil Neuroscience, Inc. (-5.26), greater than Orchard Therapeutics plc (-27.11), less than Revance Therapeutics, Inc. (-0.95), greater than Climb Bio, Inc. (-14.68), greater than G1 Therapeutics, Inc. (-7.72), greater than scPharmaceuticals Inc. (-5.38), greater than Y-mAbs Therapeutics, Inc. (-25.63), less than iTeos Therapeutics, Inc. (-2.82), greater than SomaLogic, Inc. (-3.54), greater than Inozyme Pharma, Inc. (-4.67),

Build a custom stock screener for Checkpoint Therapeutics, Inc. (CKPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Checkpoint Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Checkpoint Therapeutics, Inc. (CKPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Checkpoint Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Checkpoint Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Checkpoint Therapeutics, Inc. (CKPT)?

What is the highest PE Ratio for Checkpoint Therapeutics, Inc. (CKPT)?

What is the 3-year average PE Ratio for Checkpoint Therapeutics, Inc. (CKPT)?

What is the 5-year average PE Ratio for Checkpoint Therapeutics, Inc. (CKPT)?

How does the current PE Ratio for Checkpoint Therapeutics, Inc. (CKPT) compare to its historical average?